CM-CIC
-
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month -
Sluggish orders for the €500m note limited price traction
-
Issuer postpones deal after setting spread in line with initial price thoughts
-
Spread widening has helped to keep new issue premiums down for senior sales
-
Short dated deal attracts rare insurance and corporate investors
-
Sovereign, supranational, agency and core European covered bonds will be the first asset classes to re-open the primary market
